Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension
Related Posts
Wooten C, Pillutla P, St John MA. What Is the Role of Sentinel Lymph Node Biopsy in Recurrent Head and Neck Melanoma? Laryngoscope. 2025 Jul[...]
Kamel T, Toppen W, Salahmand Y. Successful Treatment of Post-coronavirus Disease 2019 (COVID-19) Autoimmune Encephalitis With Plasmapheresis After a Failed Trial of Steroids. Cureus. 2025[...]
Emmanouilidou E, Krishnan D, Kaplan E, Moritz V, Kaloti I, Sengupta S, Czypinski L, Dowling E, Simon W, Dermenchyan A. Nursing Recommendations to Improve Discharge[...]